Breaking News Instant updates and real-time market news.

VLRS

Volaris

$5.91 /

+0.27 (+4.79%)

20:41
06/04/20
06/04
20:41
06/04/20
20:41

Volaris reports May traffic down 88.9%

The company states: "In May 2020, Volaris managed its network in response to the decline in demand for air travel due to the COVID-19 pandemic. As a result, and in line with prior capacity guidance issued by the company, capacity measured by ASMs decreased by 88.1% vs the same period of last year, while demand measured by RPMs, or Revenue Passenger Miles, decreased 88.1% year over year. Volaris transported a total of 213 thousand passengers during the month of May, a decrease of 88.9% year over year. Network-wide booked load factor for May 2020 was 87.5%, with a 105% international booked load factor."

VLRS Volaris
$5.91 /

+0.27 (+4.79%)

04/08/20 Goldman Sachs
Volaris downgraded to Neutral from Buy at Goldman Sachs
03/17/20 Deutsche Bank
Volaris downgraded to Hold from Buy at Deutsche Bank
09/17/19 Bradesco BBI
Volaris downgraded to Neutral from Outperform at Bradesco
07/29/19
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks
Air Products signs exclusive strategic cooperation agreement with thyssenkrupp » 05:17
07/06/20
07/06
05:17
07/06/20
05:17
APD

Air Products

$247.27 /

+3.52 (+1.44%)

Air Products and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APD Air Products
$247.27 /

+3.52 (+1.44%)

APD Air Products
$247.27 /

+3.52 (+1.44%)

06/16/20
Fly Intel: Top five analyst downgrades
06/16/20 HSBC
Air Products downgraded to Hold on cyclicality, valuation at HSBC
06/16/20 HSBC
Air Products downgraded to Hold from Buy at HSBC
04/24/20 JPMorgan
Air Products price target raised to $242 from $237 at JPMorgan
APD Air Products
$247.27 /

+3.52 (+1.44%)

APD Air Products
$247.27 /

+3.52 (+1.44%)

APD Air Products
$247.27 /

+3.52 (+1.44%)

Downgrade
Spotify downgraded to Underperform from Market Perform at Bernstein » 05:17
07/06/20
07/06
05:17
07/06/20
05:17
SPOT

Spotify

$271.59 /

+12.63 (+4.88%)

Bernstein analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

07/01/20 Wells Fargo
Spotify price target raised to $175 from $130 at Wells Fargo
06/30/20 Citi
Spotify initiated with a Neutral at Citi
06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 Guggenheim
Guggenheim cuts Spotify to Sell with potential podcast dominance priced in
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

Downgrade
BHP Group downgraded to Neutral from Outperform at Credit Suisse » 05:16
07/06/20
07/06
05:16
07/06/20
05:16
BHP

BHP Group

$50.07 /

+0.625 (+1.26%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHP BHP Group
$50.07 /

+0.625 (+1.26%)

BHP BHP Group
$50.07 /

+0.625 (+1.26%)

07/01/20 Deutsche Bank
BHP Group downgraded to Hold on decarbonization risk at Deutsche Bank
07/01/20 Deutsche Bank
BHP Group downgraded to Hold from Buy at Deutsche Bank
06/25/20 UBS
BHP Group price target raised to 1,850 GBp from 1,700 GBp at UBS
06/08/20 JPMorgan
BHP Group price target raised to 1,830 GBp from 1,780 GBp at JPMorgan
BHP BHP Group
$50.07 /

+0.625 (+1.26%)

BHP BHP Group
$50.07 /

+0.625 (+1.26%)

Upgrade
Close Brothers upgraded to Hold from Sell at Canaccord » 05:15
07/06/20
07/06
05:15
07/06/20
05:15
CBGPY

Close Brothers

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBGPY Close Brothers
$0.00 /

+ (+0.00%)

07/01/20 RBC Capital
Close Brothers upgraded to Outperform from Sector Perform at RBC Capital
05/27/20 Investec
Close Brothers downgraded to Sell from Hold at Investec
04/27/20 Jefferies
Close Brothers downgraded to Underperform from Hold at Jefferies
04/24/20 JPMorgan
Close Brothers price target lowered to 1,170 GBp from 1,550 GBp at JPMorgan
Downgrade
Elior Group downgraded to Sell from Neutral at Bryan Garnier » 05:14
07/06/20
07/06
05:14
07/06/20
05:14
ELROF

Elior Group

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
$0.00 /

+ (+0.00%)

05/12/20 JPMorgan
Elior Group downgraded to Neutral from Overweight at JPMorgan
05/06/20 Deutsche Bank
Elior Group price target lowered to EUR 7.30 from EUR 7.50 at Deutsche Bank
04/30/20 Deutsche Bank
Elior Group price target lowered to EUR 7.50 from EUR 7.60 at Deutsche Bank
04/16/20 JPMorgan
Elior Group price target lowered to EUR 10 from EUR 13.60 at JPMorgan
Downgrade
Software AG downgraded to Sell from Neutral at Bryan Garnier » 05:11
07/06/20
07/06
05:11
07/06/20
05:11
STWRY

Software AG

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STWRY Software AG
$0.00 /

+ (+0.00%)

07/03/20 DZ Bank
Software AG downgraded to Hold from Buy at DZ Bank
06/02/20 Morgan Stanley
Software AG price target raised to EUR 30 from EUR 28 at Morgan Stanley
04/28/20 Morgan Stanley
Software AG downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/20 Morgan Stanley
Software AG upgraded to Overweight from Equal Weight at Morgan Stanley
Downgrade
Temenos downgraded to Sell from Neutral at Bryan Garnier » 05:10
07/06/20
07/06
05:10
07/06/20
05:10
TMSNY

Temenos

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMSNY Temenos
$0.00 /

+ (+0.00%)

06/09/20 Citi
Temenos downgraded to Neutral from Buy at Citi
06/01/20 Deutsche Bank
Temenos downgraded to Hold from Buy at Deutsche Bank
05/29/20 JPMorgan
Temenos downgraded to Neutral from Overweight at JPMorgan
04/15/20 Barclays
Temenos price target lowered to CHF 109 from CHF 147 at Barclays
TMSNY Temenos
$0.00 /

+ (+0.00%)

Recommendations
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler » 05:02
07/06/20
07/06
05:02
07/06/20
05:02
BHVN

Biohaven Pharmaceutical

$71.19 /

-1.075 (-1.49%)

, ABBV

AbbVie

$98.87 /

-0.25 (-0.25%)

Per Iqvia, the latest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
06/24/20 Piper Sandler
Piper Sandler stays Overweight Biohaven after troriluzole efficacy signal in OCD
06/23/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $109 from $82 at Cantor Fitzgerald
06/19/20 Piper Sandler
Biohaven launch of Nurtec continues to impress, says Piper Sandler
ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/25/20 RBC Capital
AbbVie price target raised to $125 from $102 at RBC Capital
06/24/20 BofA
AbbVie Orilissa guidance for 2025 in more jeopardy after Myovant data, says BofA
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

Downgrade
Netflix downgraded to In-Line from Outperform at Imperial Capital » 04:58
07/06/20
07/06
04:58
07/06/20
04:58
NFLX

Netflix

$476.31 /

-9.47 (-1.95%)

Imperial Capital analyst…

Imperial Capital analyst David Miller downgraded Netflix to In-Line from Outperform with an unchanged price target of $489. The stock closed Thursday down $8.75 to $476.89. The shares are up over 50% since January 2, Miller tells investors in a research note. As a result, the analyst sees only an additional 2.5% upside in Netflix. He cites valuation for the downgrade to In-Line.

ShowHide Related Items >><<
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/30/20 Cowen
Netflix price target raised to $535 from $485 at Cowen
06/23/20 JPMorgan
Netflix user growth implies upside to Q2 guidance, says JPMorgan
06/18/20 Imperial Capital
Netflix price target raised to $489 from $485 at Imperial Capital
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

Upgrade
Xilinx upgraded to Conviction Buy from Buy at Goldman Sachs » 04:56
07/06/20
07/06
04:56
07/06/20
04:56
XLNX

Xilinx

$95.29 /

+2.01 (+2.15%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
06/30/20 Susquehanna
Xilinx price target raised to $115 from $105 at Susquehanna
06/30/20 JPMorgan
Xilinx price target raised to $88 from $85 at JPMorgan
06/30/20 Morgan Stanley
Xilinx trends less negative than feared, says Morgan Stanley
XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

Conference/Events
Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

Specialty Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS leisure, gaming & lodging analyst to hold analyst/industry conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

Leisure, Gaming &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Cloudera participates in a conference call with JMP Securities » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
CLDR

Cloudera

$12.28 /

-0.1 (-0.81%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

06/10/20 Morgan Stanley
Morgan Stanley says Cloudera could be valued at $14.50 using typical PE multiple
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
06/09/20 Northland
Northland downgrades Cloudera to Market Perform as coverage transferred
06/03/20
Fly Intel: Top five analyst upgrades
CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

Conference/Events
NetApp management to meet virtually with Oppenheimer » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
NTAP

NetApp

$43.57 /

+0.08 (+0.18%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

General news
3-Month Bill Auction to be released at 11:30  04:55
07/06/20
07/06
04:55
07/06/20
04:55
 
General news
PMI Services Index Level to be reported at 09:45 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June PMI Services Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Biohaven Pharmaceutical management to meet virtually with Piper Sandler » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
BHVN

Biohaven Pharmaceutical

$71.19 /

-1.075 (-1.49%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
06/24/20 Piper Sandler
Piper Sandler stays Overweight Biohaven after troriluzole efficacy signal in OCD
06/23/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $109 from $82 at Cantor Fitzgerald
06/19/20 Piper Sandler
Biohaven launch of Nurtec continues to impress, says Piper Sandler
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

Conference/Events
Hudson Pacific management to meet virtually with Piper Sandler » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
HPP

Hudson Pacific

$25.32 /

+0.03 (+0.12%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

06/26/20 Mizuho
Hudson Pacific shares could be worth $32-$40 with spinoff, says Mizuho
06/25/20
Fly Intel: Top five analyst downgrades
06/24/20 Morgan Stanley
Hudson Pacific cut to Equal Weight from Overweight at Morgan Stanley
04/16/20 Jefferies
Hudson Pacific initiated with a Hold at Jefferies
HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

General news
PMI Services Index Composite to be reported at 09:45 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June PMI Services Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
ObsEva to host conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
OBSV

ObsEva

$6.15 /

+0.17 (+2.84%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

03/24/20 Wedbush
ObsEva price target lowered to $34 from $40 at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 after pipeline update at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 from $36 at Wedbush
12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

General news
ISM Non-Mfg Index Composite to be reported at 10:00 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June ISM Non-Mfg Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Dominion Energy to hold a conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
BRK.A

Berkshire Hathaway

$267,661.14 /

+751.14 (+0.28%)

, D

Dominion

$82.68 /

+0.32 (+0.39%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
D Dominion
$82.68 /

+0.32 (+0.39%)

06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
05/29/20 Wolfe Research
Dominion downgraded to Peer Perform from Outperform at Wolfe Research
05/14/20 Credit Suisse
Dominion price target raised to $85 from $80 at Credit Suisse
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

General news
6-Month Bill Auction to be released at 11:30  04:55
07/06/20
07/06
04:55
07/06/20
04:55
 
Conference/Events
Immunomedics to host conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
IMMU

Immunomedics

$37.49 /

+0.55 (+1.49%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
05/29/20 Piper Sandler
Immunomedics' sacituzumab activity remains consistent, says Piper Sandler
05/28/20 H.C. Wainwright
Immunomedics CEO change to not impact Trodelvy launch, says H.C. Wainwright
IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

  • 29
    Apr
  • 05
    Dec
IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

Downgrade
Intel downgraded to Sell from Neutral at Goldman Sachs » 04:53
07/06/20
07/06
04:53
07/06/20
04:53
INTC

Intel

$59.11 /

+0.31 (+0.53%)

Goldman Sachs analyst…

Goldman Sachs analyst Toshiya Hari downgraded Intel to Sell from Neutral with a price target of $54, down from $65. The stock closed Thursday up 32c to $59.13. Recent industry checks indicate a slowdown in PC builds in the second half of 2020 and continued share loss for Intel in the client and server central processing unit markets, Hari tells investors in a research note. As a result, the analyst cut 2021 and 2022 earnings estimates to below Street levels and sees 9% downside in Intel shares.

ShowHide Related Items >><<
INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/23/20 Oppenheimer
Apple creating 'wide moat' for own ecosystem, says Oppenheimer
06/23/20 Goldman Sachs
Apple's revamped Mac rollout plans look aggressive, says Goldman Sachs
06/23/20 Raymond James
Apple's transition away from Intel to result in cost savings, says Raymond James
INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.